Data from FDA - Curated by EPG Health - Last updated 07 February 2017


1. INDICATIONS AND USAGE Indicated as a topical anesthetic for use on oral mucosa prior to local anesthetic injections, scaling and prophylaxis. Also useful to relieve discomfort associated with taking impressions and intra- oral radiographs.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Allergic Rhinitis

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

+ 4 more

Anti-integrins in IBD

Anti-integrins in IBD

See presentations from a satellite symposium presented at UEG Week 2018, with a particular focus on rapid and sustained efficacy in IBD through biologics along with a need to utilise patient-empowered treatment models.

Load more

Related Content

Advisory information

4. CONTRAINDICATIONS Should not be used with individuals with a known sensitivity to benzocaine or PABA.

Usage information

Dosing and administration
2. DOSAGE AND ADMINISTRATION ❖Using a new cotton applicator, apply a small amount of gel to the mucosa to achieve topical anesthesia. Do not reintroduce the cotton applicator into the bottle. ❖Tightly re-cap the jar after each use.

More information

Category Value
Agency product number U3RSY48JW5
Orphan designation No
Product NDC 43128-022,43128-023,43128-020,43128-021,43128-026,43128-024
Date Last Revised 13-01-2017
Storage and handling Store between 59°-86°F (15°-30°C). Protect from freezing.
Marketing authorisation holder NDC, Inc.